SignalCorporate

PTC Therapeutics sets $500M stock buyback plan

PTC Therapeutics' $500M buyback signals confidence and supports share price.

What changed

PTC Therapeutics' $500M buyback signals confidence and supports share price.

Why it matters

PTC Therapeutics' $500M buyback signals confidence and supports share price. — impact context not separately stored; see What changed.

Sources